Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
|Articles|April 13, 2015
Advice for Patients with Newly Diagnosed Glioblastoma
James Battiste, an oncologist with Stephenson Cancer Center in Oklahoma City, Okla., says patients with glioblastoma will likely have a lot of questions about the diagnosis.
Advertisement
James Battiste, an oncologist with Stephenson Cancer Center in Oklahoma City, Okla., says patients with glioblastoma will likely have a lot of questions about the diagnosis.
"First thing is don't be bashful about asking questions. Ask your oncologist as many things as possible," he says.
It is a difficult cancer to treat, but there have been advances, he says. Battiste encourages patients to seek out clinical trials and new information about the brain cancer because of the rapidly advancing field.
Advertisement
Related to this article
A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
Dr. Saum Ghodoussipour of Rutgers Cancer Institute answers top searched bladder cancer questions, from treatment and surgery side effects to sex and work.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
Dr. Robert Kreitman explains how CD22-targeted CAR T could help heavily pretreated patients.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Pancreatic Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
The Breast Cancer Test Many Patients Don’t Know to Ask For
3
3 Prostate Cancer Results From ESMO 2026 Patients Should Know
4
Why a Patient With Pancreatic Cancer Moved From Chemotherapy to Rasonque
5